Engineering a topical hypobaric patch: A needle-free solution for biopharmaceutical drug administration into the skin
Lead Research Organisation:
University of Surrey
Department Name: Chemical Engineering
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Organisations
Publications
Sebastia-Saez D
(2022)
In-Silico Modelling of Transdermal Delivery of Macromolecule Drugs Assisted by a Skin Stretching Hypobaric Device
in Pharmaceutical Research
Benaouda F
(2022)
Needleless administration of advanced therapies into the skin via the appendages using a hypobaric patch.
in Proceedings of the National Academy of Sciences of the United States of America
Sebastia-Saez D
(2021)
Numerical analysis of the strain distribution in skin domes formed upon the application of hypobaric pressure.
in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
Sebastia-Saez D
(2021)
Numerical analysis of the strain distribution in skin domes formed upon the application of hypobaric pressure.
in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
Sebastia-Saez D
(2022)
Engineering a topical hypobaric patch for needleless administration of advanced therapeutics
| Description | Advanced therapies are commonly administered via injection even when they act within the skin tissue, and this increases the chances of off-target effects. In this project, we have found the use of a skin patch containing a hypobaric chamber that induces skin dome formation to enable needleless delivery of advanced therapies directly into the skin. Finite element method modelling showed that the hypobaric chamber in the patch opened the skin appendages, thinned the skin, and compressed the appendage wall epithelia. These changes allowed direct delivery of an H1N1 vaccine antigen and a diclofenac nanotherapeutic into the skin. Fluorescence imaging and infrared mapping of the skin showed needleless delivery via the appendages. The in vivo utility of the patch was demonstrated. In silico modelling was also used together with experimental studies to elucidate the mechanisms of increased delivery. It was found that the enlargement of the hair follicle, due to hypobaric pressure, alone cannot satisfactorily explain the increased transdermal permeation. The results from the in-silico simulations suggest that the application of hypobaric pressure increases diffusion in the skin, which leads to improved overall transdermal permeation. |
| Exploitation Route | We envisage that the findings, and tools developed (both experimental methods and models, and in silico simulation methods), will be taken forward to the next stage design of the device from a laboratory prototype into a higher technology readiness level. We are exploring options for innovation funding to support the further development. |
| Sectors | Chemicals,Healthcare |
| Description | A multiplexed micro-suction biomarker extraction device to understand atopic eczema in babies |
| Amount | £461,207 (GBP) |
| Funding ID | EP/X013294/1 |
| Organisation | Engineering and Physical Sciences Research Council (EPSRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2023 |
| End | 01/2026 |
| Description | Improving the productivity of topical drug delivery through in situ academic entrepreneurship |
| Amount | £68,071 (GBP) |
| Funding ID | 75251 |
| Organisation | Innovate UK |
| Sector | Public |
| Country | United Kingdom |
| Start | 02/2021 |
| End | 07/2022 |